Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05838508 · ClinicalTrials.gov registry record · NA

Effect of Physical Activity Pattern on Cardiometabolic Health

A NA study of Lifestyle, sponsored by Brigham and Women's Hospital.

Recruiting
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT05838508: Recruiting NA study of Lifestyle, sponsored by Brigham and Women's Hospital.

NCT05838508 is a NA study of Lifestyle that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 26 participants, below the 291-participant average among 6 other Lifestyle trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05838508, a NA study of Lifestyle, is actively recruiting participants, sponsored by Brigham and Women's Hospital.

RECRUITING
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to understand the interaction between the circadian system and physical activity. Participants will: * complete 2 inpatient stays * perform moderate exercise * be provided with identical meals * have frequent blood draws * provide urine and saliva samples

Primary Outcome

mean glucose level after exercise session

Conditions Studied

Interventions

  • BEHAVIORAL Exercise intervention

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2024-10-11
Est. Completion 2026-08-30
Phase NA
Brigham and Women's Hospital

937 total trials

What NCT05838508 shows while recruiting

NCT05838508 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 291-participant average among 6 other Lifestyle trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Lifestyle appearing as the primary indexed condition, and to 1 intervention - of which Exercise intervention is the first listed.

NCT05838508 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05838508 about?

NCT05838508 is a clinical study titled "Effect of Physical Activity Pattern on Cardiometabolic Health". The goal of this study is to understand the interaction between the circadian system and physical activity. Participants will: * complete 2 inpatient stays * perform moderate exercise * be provided with identical meals * have frequent blood draws * provide urine and saliva samples

What is the current status of trial NCT05838508?

This trial is currently recruiting. It is a NA study. The enrollment target is 26 participants. The study started on 2024-10-11. Estimated completion is 2026-08-30.

What conditions does trial NCT05838508 study?

This clinical trial studies the following conditions: Lifestyle.

What interventions are being tested in trial NCT05838508?

The interventions under investigation include: Exercise intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05838508?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05838508 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lifestyle

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05838508, the US trial registry maintained by the National Library of Medicine. NCT05838508 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.